In this one-hour CME webinar, participants will learn the latest information on new topical therapeutic considerations for actinic keratosis, including the recently approved SrC kinase inhibitor.
Watch the Webinar here
CME valid through February 2022. Take the CME exam.
Neal Bhatia, MD
Director of Clinical Dermatology
Therapeutics Clinical Research
Upon completion of this live CE webinar, learners should be able to:
- Summarize new topical therapeutic strategies for the management of actinic keratosis
- Differentiate new treatment approaches from current, established AK therapy
- Select patients most appropriate for treatment with new topical therapy options
Hosted By ODAC
In Partnership With The Journal of Drugs in Dermatology
This activity is jointly provided by Creighton University Health Sciences Continuing Education & Physicians Continuing Education, Corporation.
This continuing education webinar is supported by an independent medical education grant provided by Almirall, LLC.
Creighton University Health Sciences Continuing Education designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) TM. Physicians should claim only credit commensurate with the extent of their participation in the activity. AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.
Creighton University Health Sciences Continuing Education designates this activity for 1.0 contact hours for nurses. Nurses should claim only credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education and Physicians Continuing Education Corporation. Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.